pharma · COVID19 · COVID-19 Pandemic
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group is a pharma organization headquartered in CN. Primary therapeutic focus areas include COVID19, COVID-19 Pandemic. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent re
CN HQ
1985 Founded
656 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Founded
- 1985
- Employees
- 656
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Recombinant SARS-CoV-2 Fusion Protein Vaccine
Phase 1 · mab · COVID19
Recombinant SARS-CoV-2 Fusion Protein Vaccine for COVID19 is a Phase 1 program (mab) at Livzon Pharmaceutical Group with 1 ClinicalTrials.gov record(s).
Internal code V-01-I-Booster
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Livzon Pharmaceutical Group
- Phase
- Phase 1
- Modality
- mab
- Indication
- COVID19
- Status
- completed
- Trials
- 1